BPC-157: an evidence-first guide

Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.

BPC-157 is an experimental peptide discussed in recovery communities. It has no FDA-approved therapeutic use. Much of the public discussion extends findings from laboratory or animal research beyond what human evidence can support. Products sold for human use are unapproved products, not FDA-approved medicines.